• cGMP cell banking facility

• Cell culture development labs with:
  • 6 x 5L bioreactors (batch, fed-batch, or perfusion)
  • 6 x 15L bioreactors (batch/fed batch)
  • 3 x 40L bioreactors (batch/fed batch)

• 150L cell culture pilot plant (non-cGMP)

• cGMP manufacturing line with a 1600L production bioreactor
  • Seed bioreactors (350L)
  • Batch, fed-batch, and continuous perfusion
  • Perfusion capacity up to 2000L/day via an external ATF technology

• cGMP manufacturing line with a 3000L production bioreactor
  • Seed bioreactors (750L) 
  • Batch, fed-batch, and continuous operation

The CMC ICOS Biologics Manufacturing plant has been in operation for the production of clinical products since 1997.
A separate building is used to warehouse raw materials, and a cGMP program is in place for shipping and receiving products and raw materials.